|
Jun 30
|
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
|
|
Jun 25
|
Akari Therapeutics Releases Virtual Investor “What This Means” Segment Highlighting its Recently Granted India Patent
|
|
Jun 23
|
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
|
|
Jun 18
|
Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India
|
|
May 22
|
Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
|
|
May 1
|
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
|
|
Jan 2
|
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing
|
|
Dec 14
|
Akari Therapeutics to Present at Biotech Showcase 2024
|
|
Dec 1
|
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
|
|
Nov 16
|
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
|
|
Nov 6
|
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
|
|
Sep 5
|
Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
|